BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250704T133000
DTEND;TZID=Europe/Vienna:20250704T143000
DTSTAMP:20260605T111311
CREATED:20241017T075136Z
LAST-MODIFIED:20250630T084441Z
UID:1917-1751635800-1751639400@esmit.eanm.org
SUMMARY:Alpha Emitters – The Roadmap of the Big Ones!
DESCRIPTION:The purpose of this seminar is to provide a comprehensive overview of radionuclide therapy using alpha-emitting isotopes\, focusing on their current clinical and preclinical applications. It will explore the unique advantages of alpha emitters\, such as their high linear energy transfer and short path length\, which allow for precise tumor cell killing with minimal damage to surrounding tissue. The seminar will also address key challenges\, including limited availability of suitable alpha-emitting radionuclides\, complex radiochemistry\, and safety concerns during production and handling. Emphasis will be placed on production routes\, chelation strategies\, and conjugation chemistry that enable targeted delivery to cancer cells. Finally\, the session will critically evaluate the therapeutic potential and limitations of alpha therapy\, highlighting areas for future research and clinical translation. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nParticipants will gain understanding of the advantages of alpha-emitters over beta emitter\n\n\n\nParticipants will be able to describe and explain challenges arising from applications of alpha-emitters\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nRadiochemist\, Radiopharmacists\, nuclear physicians with a research profile\, medicinal chemistry researchers\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nMatthias HerthSpeaker \n\n\n\n\n\nFilipe ElvasSpeaker \n\n\n\n\n\nDana NiculaeModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/alpha-emitters-the-roadmap-of-the-big-ones/
CATEGORIES:Live Webinars,Radiopharmaceuticals
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250605T090000
DTEND;TZID=Europe/Vienna:20250606T160000
DTSTAMP:20260605T111311
CREATED:20241017T084223Z
LAST-MODIFIED:20250522T130904Z
UID:1964-1749114000-1749225600@esmit.eanm.org
SUMMARY:GMP for Radiopharmaceuticals
DESCRIPTION:The GMP guidelines provide minimum requirements that a manufacturer of radiopharmaceuticals must meet to assure that their products are consistently high in quality\, from batch to batch\, for clinical use.  \n\n\n\nThe Basics of cGMP is a 2 days on-site ESMIT course\, providing guidance through EU-cGMP regulation for manufacturing\, testing\, and quality assurance of radiopharmaceuticals in order to ensure that a manufactured product is safe for human use. Principles regarding facilities\, equipment qualification\, controlled environmental conditions\, processes and methods validation\, standard operation procedures and user specific requirement\, risk assessment\, and specifications will be detailed. Also\, the main components of investigational new drug and marketing authorisation dossiers will be discussed. \n\n\n\n\n\n\n\nRegister nowThe registration is closed. Please contact us at esmit@eanm.org if you still want to register. \n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nGeneral knowledge regarding GMP and cGMP for Radiopharmaceuticals principles and guidelines. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nRadiopharmacists and radiochemists in translational research\, hospital radiopharmacy and radiopharmaceutical production centres. \n\n\n\n \n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDana NiculaeSpeakerBucharest\, Romania \n\n\n\n\n\nPhilip ElsingaSpeakerGroningen\, Netherlands \n\n\n\n\n\nAntero AbrunhosaSpeakerCoimbra\, Portugal \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/gmp-for-radiopharmaceuticals/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course,Radiopharmaceuticals
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250601T000000
DTEND;TZID=Europe/Vienna:20250601T235959
DTSTAMP:20260605T111311
CREATED:20251030T142906Z
LAST-MODIFIED:20251031T095911Z
UID:1346-1748736000-1748822399@esmit.eanm.org
SUMMARY:Bringing Alpha Therapies into Clinical Practice
DESCRIPTION:UEMS EACCME has granted the accreditation of 3 CME credits for this event. \n\n\n\n \n\n\n\n \n\n\n\nThis online course offers a comprehensive introduction to alpha therapy in nuclear medicine\, with a focus on the fundamental principles and clinical applications of Alpha-Therapy in the fields of Radiopharmaceutical Sciences\, Oncology and Dosimetry. Alpha Therapy is a cutting-edge cancer treatment using alpha radiation. It represents a form of targeted radionuclide therapy that uses alpha-emitting radioisotopes to deliver lethal doses of radiation directly to cancer cells while sparing healthy tissues. It is highly efficient and lately increasingly explored for scientific purposes in the oncologic domain . With this course we aim at bringing Alpha Therapies into clinical practice through various\, relevant presentations. A panel of experts and EANM members will update you on the type of alpha-emitting radioisotopes available\, describing all important steps required for production and radiopharmaceutical development. The advantages\, but also the challenges related to the use of Alpha therapy will amply be discussed and supported by clinical examples. You will be initiated in the existing and ongoing therapeutic trials\, with the best yet to come. Dosimetry will play a pivotal role in this course\, underlying its role in clinical practice. Finally\, The Alphamet project will be presented\, allowing you to get updated with the latest insights from Theranostics. \n\n\n\nRPH \n\n\n\nTargeted Alpha Therapy (TAT) represents a cutting-edge advancement in cancer treatment\, harnessing the potent\, cell-killing power of alpha particles to precisely destroy malignant cells while minimizing damage to surrounding healthy tissue. This part of the course course explores the transformative potential of TAT\, highlighting its exceptional potency\, unique ability to overcome radio-resistance\, and its role in modern theranostics. You’ll gain insight into the selection of optimal alpha-emitting radionuclides\, the biological advantages of short-range high-energy emissions\, and the complex challenges involved in the development\, production\, and clinical translation of these innovative therapies. Join us to deepen your knowledge and be part of the future of targeted radiopharmaceuticals in oncology. \n\n\n\nOncology \n\n\n\n \n\n\n\nIn this part of the course\, participants will explore the main advantages of alpha-emitting radionuclides in oncology\, while also gaining an understanding of the clinical challenges associated with their use. You will become familiar with the key clinical aspects of Alpha-Therapy\, supported by real-world perspectives and case insights. The course also highlights current and upcoming therapeutic trials\, providing valuable knowledge on the future direction of this rapidly evolving field. \n\n\n\nDosimetry \n\n\n\nParticipants will begin by exploring the basic concepts of dosimetry with alpha emitters\, highlighting key differences from beta emitter dosimetry. The course then delves into the clinical relevance of alpha dosimetry\, demonstrating how accurate dose assessments can inform and optimize the management of patients undergoing treatment with alpha radiotherapeutics. In addition\, the course presents the Alphamet project\, a major European initiative that addresses the specific metrological challenges associated with targeted alpha therapies. By examining the goals and contributions of Alphamet\, learners will gain insight into how this research supports the safe and effective integration of alpha therapy into routine clinical practice. \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTo gain an overview of the main advantages of Alpha-radionuclides\n\n\n\nTo learn about the challenges of alpha emitters\, complex production; transport issues\, waste management and handling\n\n\n\nTo get insights on radiobiology: radiotoxicity & effectiveness\n\n\n\nTo have a comprehensive review of research candidates\n\n\n\nTo provide an overview of the main advantages when using Alpha-Therapy in clinical practice\n\n\n\nTo learn about the clinical challenges when using Alpha-Therapy\n\n\n\nTo get insights into current and future trials focusing on Alpha-Therapy\n\n\n\nTo learn the most basic aspects about dosimetry of alpha emitters showing the main differences with dosimetry of beta emitters\n\n\n\nTo learn how dosimetry results could be used in the management of patients treated with radiopharmaceuticals that include alpha emitters\n\n\n\nTo learn on the Alphamet project\, which addresses the unique and unmet metrological challenges of targeted alpha therapies\, contributing to their safe and optimised implementation into routine clinical practice\n\n\n\n\n\n\n\nNuclear medicine physicians\, radiologists\, medical oncologists\, urologists\, radiation oncologists\, medical physicists\, biologists\, researchers\n\n\n\nRadiochemists\, radiopharmacists\, physicists\, medical physicists\, biologists\n\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the full event programme.  View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nDana NiculaeSpeaker \n\n\n\nMarianna TosatoSpeaker \n\n\n\nPablo Mínguez GabiñaSpealer \n\n\n\nAna Denis-BacelarSpeaker \n\n\n\n\n\nEmma AnaheimSpeaker \n\n\n\nWolfgang FendlerSpeaker \n\n\n\nMike SathekgeSpeaker \n\n\n\nJoe O’SullivanSpeaker \n\n\n\n\n\nJanke KleynhansSpeaker \n\n\n\nMathias ZacherlSpeaker \n\n\n\nDaniela Oprea-LagerSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\nEnroll yourselfFind your desired course under ‘Online Courses’  \n\n\n\nEnjoy!Once registered\, you get full access to the course contents on the ESMIT eLearning platform \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/bringing-alpha-therapies-into-clinical-practice/
LOCATION:Online
CATEGORIES:Clinical Nuclear Medicine,Online Course,Radiopharmaceuticals,Self-paced Online Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240412T133000
DTEND;TZID=Europe/Vienna:20240412T143000
DTSTAMP:20260605T111311
CREATED:20240213T185351Z
LAST-MODIFIED:20240402T110609Z
UID:1255-1712928600-1712932200@esmit.eanm.org
SUMMARY:Basic GMP and the Challenges of Annex 1: Manufacture of Sterile Products
DESCRIPTION:This webinar will give an introduction into the GMP rules\, basics and application to radiopharmaceutical productions. \n\n\n\nLearning Objectives: The aim of the webinar is to deliver the basic of GMP applied to radiopharmaceutical production. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nHendrikus BoersmaSpeakerHospital Pharmacist/ Clinical Pharmacologist\, QP\, Section Co-ordinator Radiochemistry and Radiopharmacy\, Assistant Professor\, Hospital Pharmacist for Radiopharmacy and Clinical Trials support\, Department of Clinical Pharmacy and Pharmacology UMCG AP50\, Department of Nuclear Medicine and Molecular Imaging\, University Medical Center Groningen\, Netherlands \n\n\n\n\n\nNeil HartmanSpeakerHead of Nuclear Medicine\, Swansea Bay University Health Board\, Singleton Hospital\, Swansea\, United Kingdom \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/basic-gmp-and-the-challenges-of-annex-1-manufacture-of-sterile-products/
CATEGORIES:Live Webinars,Radiopharmaceuticals
END:VEVENT
END:VCALENDAR